How one company carved itself a piece of the anti-aging industry pie
When it comes to aging, consumers don't slow down for science. The pleas of thousands, starving for a pill that will slow, stop, or reverse the inevitable, clog the Internet. With an insatiable desire for something that doesn't yet exist, people are using themselves as test subjects, and shelling out millions - perhaps billions - of dollars on products unsupported by science. In some cases, they may not even know what they're taking.
Case in point: a product called Protandim. When a deal between two companies to sell the product fell through, one appeared to keep the name but changed the formulation, leaving a glut of information in chat rooms, blogs, and news articles that describes Protandim, but doesn't always specify which one.
In November, Lifeline Therapeutics announced that in just three months it had sold close to ...
